Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
AngioDynamics Inc. logo

AngioDynamics Inc.

Sector: Healthcare   

Industry: Medical Instruments & Supplies

6.26
 
USD
  
0.14
  
(2.29%)
Optionable: Yes  Market Cap: 261 M  90-day average vol: 528,738

Previous close: 6.12  Open: 5.985  Bid: 5.6  Ask: 7.17
52 week range    
5.26   
   11.38
Peers   
LMAT / 
MMSI / 
TFX / 
ICUI / 
BSX / 
Last updated: Monday 22nd April 2024
47
MarketXLS Rank
60
Value
46
Technical
36
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

ANGO Income Statement

Annual
May-14May-15May-16May-17May-18May-19May-20May-21May-22May-23
AcquiredInProcessRnD10 M
AcquiredInProcessRnDIncome-8 M
Amortization of intangibles17 M18 M18 M17 M14 M17 M18 M18 M20 M19 M
Basic EPS from continuing operations-0.17-0.3-4.39-0.82-0.68-1.33
Basic EPS total0.08-0.09-1.210.140.441.63-4.39-0.82-0.68-1.33
Basic weighted shares outstanding35 M36 M36 M37 M37 M37 M38 M38 M39 M39 M
BasicDiscontinuousOperations0.611.93
Cost of sales-175 M-181 M-180 M-173 M-118 M115 M114 M134 M150 M165 M
Depreciation-8 M-10 M-8 M-6 M-3 M3 M3 M6 M8 M12 M
Depreciation unreconciled17 M18 M18 M17 M14 M17 M18 M18 M20 M19 M
DepreciationAndAmortization17 M18 M18 M17 M14 M17 M18 M18 M20 M19 M
Diluted EPS total0.08-0.09-1.210.140.441.63-4.39-0.82-0.68-1.33
Diluted normalized net income/share-0.17-0.3-4.39-0.82-0.68-1.33
Diluted weighted shares outstanding35 M36 M36 M37 M37 M37 M38 M38 M39 M39 M
DilutedDiscontinuousOperations0.611.93
Earnings from equity interest-36 M
EarningsFromEquityInterestNetOfTax-36 M
GainOnSaleOfBusiness6 M
GainOnSaleOfPPE-168 M
GeneralAndAdministrativeExpense27 M29 M31 M31 M31 M35 M38 M36 M38 M40 M
Gross operating profit180 M176 M174 M144 M144 M156 M150 M157 M166 M174 M
ImpairmentOfCapitalAssets159 M15 M
Income before tax6 M-8 M-3 M10 M-17 M-15 M-168 M-36 M-30 M-54 M
Income restructuring and M&A-1 M-5 M288000.026000.0
Income taxes3 M-5 M40 M5 M-11 M-4 M-1 M-5 M-3 M-2 M
Interest income4000.011000.0
InterestExpenseNonOperating4 M3 M3 M3 M3 M5 M907000.0861000.0688000.03 M
MiscOtherSpecialCharges-4 M-10 M-886000.010 M-31000.0-15 M-130000.092000.0-790000.0-554000.0
Net income from total operations8 M-12 M-47 M15 M-23 M61 M-167 M-32 M-27 M-52 M
NetIncomeCommonStockholders8 M-12 M-47 M15 M-23 M-9 M-178 M9 M-6 M-17 M
NetIncomeContinuousOperations8 M-12 M-47 M15 M-23 M61 M-167 M-32 M-27 M-52 M
NetIncomeDiscontinuousOperations23 M72 M
NetNonOperatingInterestIncomeExpense-4 M-3 M-3 M-3 M-3 M-5 M-907000.0-861000.0-688000.0-3 M
Normalized income-42 M
Operating income13 M-3 M1 M13 M-14 M-9 M-167 M-35 M-28 M-51 M
Operating income before depreciation (EBITDA)38 M25 M28 M37 M9 M16 M-143 M-9 M88000.0-21 M
OperatingExpense-167 M-179 M-173 M-163 M-158 M165 M317 M192 M194 M225 M
Other income net-2 M10 M886000.0-10 M17 M15 M130000.0-92000.0790000.0554000.0
OtherGainLossFromDispositionOfDiscontinuedOperations72 M
OtherGandA27 M29 M31 M31 M31 M35 M38 M36 M38 M40 M
OtherImpairmentOfCapitalAssets-100000.0
OtherOperatingExpenses13 M22 M16 M10 M16 M-8 M6 M-20 M-10 M-18 M
RealizedCapitalGain7 M
RentAndLandingFees27 M29 M31 M31 M31 M3 M
Research & development expense27 M27 M25 M25 M24 M28 M30 M36 M31 M30 M
ResearchExpense27 M27 M25 M25 M24 M28 M30 M36 M31 M30 M
RestructringAndMnAIncome-1 M-5 M288000.026000.0
Revenue per share17 M18 M18 M17 M14 M17 M18 M18 M20 M19 M
SalariesAndWages-6 M-6 M-3 M-6 M-8 M-2 M-2 M-2 M-2 M-3 M
Selling Gen & administrative expense110 M112 M114 M110 M104 M112 M117 M117 M134 M144 M
SellingAndMarketingExpense83 M83 M84 M79 M73 M77 M79 M81 M95 M104 M
SellingExpense83 M83 M84 M79 M73 M
Special income/charges1 M5 M-288000.0-159 M-15 M
Total Income available for interest expense (EBIT)9 M-5 M132000.013 M-14 M-10 M-167 M-35 M-29 M-52 M
Total common shares outstanding35 M36 M36 M37 M37 M37 M38 M38 M39 M40 M
Total net income8 M-12 M-47 M15 M-23 M61 M-167 M-32 M-27 M-52 M
Total ordinary shares40 M40 M40 M40 M40 M40 M40 M40 M40 M40 M
Total revenues354 M357 M354 M350 M262 M271 M264 M291 M316 M339 M
TotalExpenses-341 M-360 M-353 M-337 M-276 M280 M431 M326 M345 M390 M
TotalRevenue354 M357 M354 M270 M262 M271 M264 M291 M316 M339 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University